tamine Lispro:activity profile of s.c.administration wih and without admixture of soluble lispro.Diabetologia,1996,39(suppll):A224.
2 Heise T,Weyer C,Serwas A,et al.Time action profiles of novel premixed preparations of insulin lispro and NPL insulin.Diabetes Care,1998,21:800-803.
3 Roac P,Yue L,Aroru V.The Humalog Mix 25 Study Group.Improved postpranclial glycemic control during treatment with Humalog Mix25,a novel protaminebased insulin lispro formulation.Diabetes Care,1999,22:1258-1261.
4 Roach P,Trautmann M,Arora V,et al.Improved postpranclial bloodglucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations Insulin lispro Mix 50.Clin Ther,1999,21:523-534.
上一页 [1] [2]
您现在的位置： 绿色健康网 >> 医学论文 >> 药学论文 >> 正文